Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OBALON THERAPEUTICS INC | 27,250 | reported | 16 Sept 2020 | tx 17+1,249,972 |
| TELA Bio, Inc. | 11,925 | reported | 31 Oct 2025 | tx 2+29,475 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Oct 2025 | GRANT_AWARD | TELA Bio, Inc. | 11,925 | 0.00 USD | |
| 31 Oct 2025 | GRANT_AWARD | TELA Bio, Inc. | 17,550 | 0.00 USD | deriv |
| 16 Sept 2020 | GRANT_AWARD | OBALON THERAPEUTICS INC | 27,250 | 0.00 USD | deriv |
| 16 Sept 2020 | GRANT_AWARD | OBALON THERAPEUTICS INC | 27,250 | 0.00 USD | deriv |
| 24 Jan 2020 | GRANT_AWARD | OBALON THERAPEUTICS INC | 441,125 | 0.00 USD | deriv |
| 12 Nov 2019 | PURCHASE | OBALON THERAPEUTICS INC | 65,000 | 1.66 USD | |
| 25 Oct 2019 | GRANT_AWARD | OBALON THERAPEUTICS INC | 10,000 | 0.00 USD | deriv |
| 06 Aug 2019 | PURCHASE | OBALON THERAPEUTICS INC | 12,500 | 4.00 USD | |
| 06 Aug 2019 | PURCHASE | OBALON THERAPEUTICS INC | 9,375 | 0.00 USD | derivfirst after silence |
| 23 Jul 2019 | GRANT_AWARD | OBALON THERAPEUTICS INC | 300,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | OBALON THERAPEUTICS INC | 100,000 | 0.00 USD | deriv |
| 23 Aug 2018 | GRANT_AWARD | OBALON THERAPEUTICS INC | 27,472 | 1.82 USD | |
| 15 May 2018 | GRANT_AWARD | OBALON THERAPEUTICS INC | 45,000 | 0.00 USD | |
| 13 Mar 2018 | PURCHASE | OBALON THERAPEUTICS INC | 9,700 | 4.05 USD | |
| 14 Mar 2018 | PURCHASE | OBALON THERAPEUTICS INC | 5,412 | 4.04 USD | |
| 13 Mar 2018 | PURCHASE | OBALON THERAPEUTICS INC | 9,588 | 4.05 USD | |
| 14 Mar 2018 | PURCHASE | OBALON THERAPEUTICS INC | 5,300 | 4.04 USD | |
| 02 Jan 2018 | GRANT_AWARD | OBALON THERAPEUTICS INC | 100,000 | 0.00 USD | deriv |
| 09 Nov 2016 | GRANT_AWARD | OBALON THERAPEUTICS INC | 55,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 06 Aug 2019.